Abortion Incidence and Severity of Complications in Kenya 2022, Health Facilities Survey (HFS)

Kenya, 2023
Health and Well-Being (HaW)

Kenneth Juma

Variable Groups

Variable group: Abortion Complication Caseloads

Variables 125

q401

401. In your facility, are postabortion care (PAC) patients treated as outpatie

q402u

q402u_name

q402b

b. Specify Number of post-abortion care patients

q403u

q403u_name

q403b

b. Specify Number of post-abortion care patients

q404u

q404u_name

q404b

b. Specify Number of post-abortion care patients

q405u

q405u_name

q405b

b. Specify Number of post-abortion care patients

q402b_nr0

q404b_nr0

q403b_nr0

q405b_nr0

average_caseload_pyr

total_past_caseload_pyr

avg_outpatients_per_year

avg_inpatients_per_year

past_outpatients_per_year

past_inpatients_per_year

q402u_mth

q402u_yr

q404u_mth

q404u_yr

q403u_mth

q403u_yr

q405u_mth

q405u_yr

average_equal_unit_mth

past_equal_unit_mth

average_equal_unit_yr

past_equal_unit_yr

q406

Q406. Just to confirm what you have told me, in an average year this facility t

q407

Q407. Just to confirm, in the previous year this facility treated [${past_outpa

q407a

Q406. Just to confirm what you have told me, in an average this f

q407b

Q407. Just to confirm, in the previous this facility treated [${

q406_q407outp

Q406. Just to confirm what you have told me, in an average this f

q406_q407inp

Q406. Just to confirm what you have told me, in an average this f

q408a

a. Dilation & Evacuation (D&E)

q408b

b. Dilation and curettage (D&C)

q408c

c. MVA (manual vacuum aspiration)

q408d

d. EVA (electric vacuum aspiration)

q408e

e. Surgery only (e.g. laparotomy)

q408f

f. Medical abortion (Misoprostol alone/mifepristone combined with misoprostol

q408x

q408x_spy

408. Please specify Other

q408_total

q409

409. We want to understand the distribution of PAC patients served who come fro

q410u

q410u_name

q410b

410.b. Specify number of patients requesting termination of pregnancy [Enter 88

q411u

q411u_name

q411b

b.Specify number of patients requesting termination of pregnancy [Enter 8888 fo

q412a

a. Any surgical method

q412b

b. Misoprostol in combination with Mifepristone

q412c

c. Misoprostol alone

q412d

q412d_spy

412.d Please specify other methods used.

q412_total

q413

413. Again, we want to understand the distribution of TOP patients served who a

q414

414. Thinking of all patients who come to this facility for termination of preg

q415

415.On a scale of 1 to 10, with 1 being 'not at all sure' and 10 being 'very su

q416

416On a scale of 1 to 10, with 1 being 'not at all sure' and 10 being 'very sur

q417u

q417u_name

q417b

b. Specify Number of post-abortion care patients

inref_nr0

inref_year

inref_month

inref_chkfill

inref_nfill

inref_pacfill

q418u

q418u_name

q418b

b. Specify Number of post-abortion care patients

outref_nr0

outref_year

outref_month

outref_chkfill

outref_nfill

outref_pacfill

q419

419. Using your best estimate, what percentage of women who are treated for PAC

q420

420. What do you think are the barriers that keep women from going to a higher-

q420_1

q420_2

q420_3

q420_4

q420_5

q420_6

q420_7

q420_8

q420_9

q420_96

q420_98

q420_97

q420_99

q420a_spy

420a. Enter the other barrier(s) that might keep women from going to a higher-l

q421

421. In your opinion, how could treatment for abortion complications be improve

q421_1

q421_2

q421_3

q421_4

q421_5

q421_6

q421_7

q421_8

q421_9

q421_10

q421_11

q421_12

q421_13

q421_14

q421_15

q421_16

q421_17

q421_18

q421_96

q421_98

q421_97

q421_99

q421_spy

421. . Enter other ways in which treatment for abortion complications could be